![2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1'-oxide](https://static.cymitquimica.com/cas-image/268392-23-bipyridine-5-chloro-6-methyl-3-4-methylsulfonyl-phenyl-1-oxide.png)
CAS: 325855-74-1 - 2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1'-oxide
Formula:C18H15ClN2O3S
![5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridine] 1'-oxide](https://static.cymitquimica.com/products/IN/thumb/DA00C93X.jpg)
5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridine] 1'-oxide
CAS:325855-74-1
Formula:
C18H15ClN2O3S
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
374.8413
Ref: IN-DA00C93X
| 50mg | 118,00 € |
Consegna stimata in Stati Uniti, il Venerdì 29 Novembre 2024
Etoricoxib N-Oxide 1
CAS:325855-74-1
Formula:
C18H15ClN2O3S
Colore e forma:
White To Off-White Solid
Peso molecolare:
374.84
Ref: 4Z-E-454
| 10mg | 761,00 € | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 29 Novembre 2024
Etoricoxib N1'-oxide
Prodotto ControllatoCAS:325855-74-1
Formula:
C18H15ClN2O3S
Colore e forma:
Neat
Peso molecolare:
374.84
Ref: 04-C13365100
| 10mg | 187,00 € |
Consegna stimata in Stati Uniti, il Martedì 03 Dicembre 2024
Etoricoxib N1’-Oxide
Prodotto ControllatoCAS:325855-74-1
Applications Etoricoxib N1’-Oxide is an impurity of Etoricoxib (E934100). References Friesen, R., et al.: Bioorg. …
Formula:
C18H15ClN2O3S
Colore e forma:
Off White Solid
Peso molecolare:
374.84
Ref: TR-E934115
| 10mg | 348,00 € | ||
| 100mg | 2.323,00 € |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
Etoricoxib N-Oxide
CAS:325855-74-1
Etoricoxib N-Oxide is a non-steroidal anti-inflammatory drug (NSAID) that is used to treat inflammation and …
Formula:
C18H15ClN2O3S
Purezza:
Min. 95%
Peso molecolare:
374.8 g/mol
Ref: 3D-FE179779
| 1mg | 138,00 € | ||
| 2mg | 194,00 € | ||
| 5mg | 310,00 € | ||
| 10mg | 436,00 € | ||
| 25mg | 582,00 € |
Consegna stimata in Stati Uniti, il Giovedì 09 Gennaio 2025
